 Leuven, BE, Boston, MA, US March 8, 2021 08.00 AM CET Oxurion NV Euronext Brussels: OXUR, a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, with a clinical stage portfolio in diabetic eye disease, today announces its management will participate and meet with investors at the following upcoming virtual meetings in March: H.C. Wainwright Global Life Sciences Conference - March 9-10, 2021 Pre-Recorded Company Presentation, featuring Tom Graney, CFA, CFO to be made live on March 9 at 7:00 am EST.The presentation will be available in the events section of Oxurions website at replay will be available for approximately 90 days following the conference. 